Latest News for: biocon

Edit

Graft Versus Host Disease Market Expected to rise, 2034 | Biocon, medac GmbH, MaaT Pharma, ...

GetNews 12 Mar 2025
The graft versus host disease companies are Biocon, medac GmbH, MaaT Pharma, ElsaLys Biotech, Glia, Syndax Pharmaceuticals, ASC Therapeutics, SCM Lifescience, REGiMMUNE, Roche, ... Equillium/Biocon.
Edit

Biocon shares in focus after successful results of Yesintek in Phase 3

The Economic Times 10 Mar 2025
Biocon's shares have risen by 18.31% over the past year ... .
Edit

Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis

PR Newswire 07 Mar 2025
BRIDGEWATER, N.J., and BENGALURU, India, March 7, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd ... About Biocon Biologics Limited... BIOCON, ISIN Id.
Edit

Biocon Biologics to supply Insulin Aspart drug substance to Civica for US market

Business Line 06 Mar 2025
Biocon Biologics Ltd, a fully integrated global biosimilars company and a subsidiary of Biocon, has announced a ...
Edit

Stocks to watch: Biocon, Coforge, Adani Wilmar, Ola Electric, Power Grid among shares to remain ...

Live Mint 05 Mar 2025
Here’s a quick look at stocks likely to be in focus in today's trade ....
Edit

Biocon shares up 3% after US FDA nod for key cancer drugs

The Economic Times 05 Mar 2025
Biocon share price. Shares of Biocon Ltd rose 3% after Biocon Pharma ...
  • 1
×